Replies to post #4996 on Geron Corp (GERN)

[Charleston]

The FDA granted fast track having assessed the safety profile. The drug is extending life beyond all expectations for RR patients. The world needs Imetelstat to fill a dire gap. FDA approval is a question of 2018 vs 2019.